Roman Necina, Chief Technology Officer, is responsible for HOOKIPA’s manufacturing operations including analytical and process development relevant activities. Prior to joining HOOKIPA Roman served as General Manager of Shire Innovations Austria and as SVP Chief Strategist R&D at Takeda. In his capacity as SVP Process Science & Technology Services of Shire Plc. he had global responsibility for all CMC relevant aspects for Shire’s development and commercial product portfolio, including small molecules, plasma derived product recombinant proteins and gene therapy programs. He was responsible for the development and implementation of product specific manufacturing strategies and led Shire’s global innovation initiative on behalf of operations. During this time he successfully implemented a state-of-the-art AAV platform process and positioned Shire’s Gene Therapy Center Austria as one-stop-shop for internal and external AAV based gene therapy products. He also served as Board Member for Baxter AG Austria. Previously, he held SVP level positions at Intercell and Boehringer, leading plant expansions, establishing global manufacturing networks and leading change management processes. He is also a senate member of the Austrian Academy of Sciences. He obtained his PhD from the University of Natural Resources and Applied Life Sciences in Vienna.